期刊文献+

基于TCGA胰腺癌数据集识别胰腺癌相关糖尿病特征基因

Identification of the feature genes of pancreatic cancer-associated diabetes mellitus based on the pancreatic cancer cohort from TGCA
原文传递
导出
摘要 目的:探讨胰腺癌相关糖尿病(PCDM)的基因特征,筛选潜在的分子标志物。方法:收集来自癌症基因组图谱(TCGA)-胰腺癌(PC)数据集的临床数据,根据PC确诊前2年内是否诊断糖尿病,将患者分为PCDM组(11例)和PC组(109例)。提取TCGA-PC数据集mRNA的芯片表达谱数据,通过R软件"limma"程序包进行两组基因差异表达分析,以"|log 2(fold change)|>2且P<0.05"为条件筛选差异基因(DEGs),并进行基因本体(GO)和京都基因与基因组百科全书(KEGG)通路富集分析,最后通过STRING数据库构建蛋白相互作用(PPI)网络,通过Cytoscape软件MCODE模块筛选枢纽基因。结果:TCGA-PC数据集mRNA基因差异分析显示,20531个基因中47个在PCDM组高表达,60个低表达。GO分析显示107个DEGs在生物学功能方面主要参与正向调节细胞分泌功能(基因数=9,P<0.01),在分子功能方面主要集中于受体功能调节(基因数=10,P<0.01),在细胞组分方面主要与细胞质微管腔内成分相关(基因数=8,P<0.01)。KEGG通路富集分析显示,107个DEGs可能通过细胞因子相互作用(基因数=8,P<0.01)影响PCDM。PPI网络分析显示,GNG8、CNR2、GALR2、CXCL13、NPY2R可能是PCDM相关的枢纽基因。结论:PCDM与PC在细胞分泌功能、受体功能、细胞质微管成分及细胞因子相互作用方面存在基因差异。GNG8、CNR2、GALR2、CXCL13、NPY2R可能成为PCDM的潜在分子标志物。 Objective To investigate the genetic characteristics of pancreatic cancer-associated diabetes mellitus(PCDM)and screen out the possible molecular markers for PCDM.Methods The clinical data of pancreatic cancer(PC)cohort from The Cancer Genome Atlas(TCGA)were selected and collected,and the patients were divided into PCDM(n=11)and PC groups(n=109)according to whether the patients were diagnosed as diabetes within 2 years of PC diagnosis.Then,the mRNA microarray data of genome expression were extracted from TCGA PC cohort,and the differentially expressed genes(DEGs)were screened out by the"limma"package of R software based on(|log2 fold change|>2 and P<0.05).The functions of DEGs were revealed with gene ontology(GO)and Kyoto Encyclopedia of Genes and Genomes(KEGG)pathway enrichment analysis.Finally,a protein-protein interaction(PPI)network was constructed with the STRING database,and the hub genes were identified by the molecular complex detection(MCODE)module of Cytoscape software.Results The analysis showed that among 20531 genes,47 genes were significantly upregulated,and 60 genes were significantly downregulated in the PCDM group.GO analyses revealed that 107 DEGs were mainly involved in the positive regulation of secretory function in terms of biological function(gene number=9,P<0.01);in the regulation of receptor function of molecular function(gene number=10,P<0.01);and in the intracavitary components of cytoplasmic microtubules of cellular components(gene number=8,P<0.01).The results of KEGG pathway enrichments revealed that DEGs mainly affected PCDM via cytokine interactions(gene number=8,P<0.01).Finally,five hub genes,including GNG8,CNR2,GALR2,CXCL13,and NPY2R,were identified for PCDM in PPI network analysis.Conclusions The feature genes of PCDM are mainly different from PC in terms of secretion function,receptor function,cytoplasmic microtubule composition,and cytokine interaction.Five genes including GNG8,CNR2,GALR2,CXCL13,and NPY2R may become potential molecular markers for PCDM.
作者 王新静 赵昕 张欣雪 曹迪 任章勇 贾利猛 郎韧 贺强 Wang Xinjing;Zhao Xin;Zhang Xinxue;Cao Di;Ren Zhangyong;Jia Limeng;Lang Ren;He Qiang(Department of Hepatobiliary,Pancreatic and Splenic Surgery,Chaoyang Hospital,Capital Medical University,Beijing,100020;Department of General Surgery,Beijing Haidian Hospital,Beijing 100080,China)
出处 《中华胰腺病杂志》 CAS 2020年第4期271-277,共7页 Chinese Journal of Pancreatology
基金 北京市自然科学基金(7194274) 北京首都临床特色专项基金(Z181100001718164)。
关键词 胰腺肿瘤 糖尿病 胰腺癌相关糖尿病 癌症基因组图谱 Pancreatic neoplasms Diabetes mellitus Pancreatic cancer-associated diabetes mellitus The Cancer Genome Atlas
  • 相关文献

参考文献6

二级参考文献42

  • 1Ajuebor MN,Swain MG. Role of chemokines and ehemokine receptors in the gastrointestinal tract[J].Immunology,2002.137-143.
  • 2Moiler DE,Flier JS. Insulin resistance mechanisms,syndromes,and implications[J].New England Journal of Medicine,1991.938-948.
  • 3ChaveyC,Fajas L. CXCL5 drives obesity to diabetes,and further[J].Aging (Albany NY),2009.674-677.
  • 4Takahashi M,Takahashi Y,Takahashi K. CXCL14 enhances insulin-dependent glucose uptake in adipocytes and is related to high-fat diet-induced obesity[J].Biochemical and Biophysical Research Communications,2007.1037-1042.
  • 5Hara T,Nakayama Y. CXCL14 and insulin action[J].VITAMINS AND HORMONES-ADVANCES IN RESEARCH AND APPLICATIONS,2009.107-123.
  • 6Nara N,Nakayama Y,Okamoto S. Disruption of CXC motif chemokine ligand-14 in mice Ameliorates obsity-induced insulin resistance[J].Journal of Biological Chemistry,2007.30794-30803.
  • 7Morimoto J,Yoneyama H,Shimada A. CXC chemokine ligand 10 neutralization suppresses the occurrence of diabetes in nonobese diabetic mice through enhanced beta cell proliferation without affecting insulitis[J].Journal of Immunology,2004.7017-7024.
  • 8Roep BO,Kleijwegt FS,van Halteren AG. Islet inflammation and CXCL10 in recent-onset type 1 diabetes[J].Clinical and Experimental Immunology,2010.338-343.
  • 9Herder C,Baumert J,Thorand B. Chemokines as risk factors for type 2 diabetes:results from the MONICA/KORA Augsburg study,1984-2002[J].Diabetologia,2006.921-929.
  • 10Herder C,Sehneitler S,Rathmann W. Low grade in flammation,obesity,and insulin resistance in adolescents[J].Endocrinology and Metabolism Clinics of North America,2007.4569-4574.

共引文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部